Oyster Point Pharma, Inc. Operating Lease Right-of-Use Assets
Oyster Point Pharma, Inc. had Operating Lease Right-of-Use Assets of $2.44 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2022-11-10
- 2022-09-30: Operating Lease, Right-of-Use Asset $2.44M.
- 2022-06-30: Operating Lease, Right-of-Use Asset $2.64M.
- 2022-03-31: Operating Lease, Right-of-Use Asset $2.65M.
- 2021-12-31: Operating Lease, Right-of-Use Asset $2.88M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2022-09-30 | $2.44M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $2.64M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $2.65M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $2.88M 10-Q · filed 2022-11-10 | |
| 2021-09-30 | $629.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $757.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $882.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $644.00K 10-K · filed 2022-02-24 | |
| 2020-09-30 | $739.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $832.00K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $923.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $783.00K 10-K · filed 2021-02-18 | $797.00K 10-K · filed 2020-02-27 |
| 2019-09-30 | $879.00K 10-Q · filed 2019-12-03 | |
| 2018-12-31 | $66.00K 10-K · filed 2020-02-27 |